Cargando…

Co-Application of Statin and Flavonoids as an Effective Strategy to Reduce the Activity of Voltage-Gated Potassium Channels Kv1.3 and Induce Apoptosis in Human Leukemic T Cell Line Jurkat

Voltage-gated potassium channels of the Kv1.3 type are considered a potential new molecular target in several pathologies, including some cancer disorders and COVID-19. Lipophilic non-toxic organic inhibitors of Kv1.3 channels, such as statins and flavonoids, may have clinical applications in suppor...

Descripción completa

Detalles Bibliográficos
Autores principales: Teisseyre, Andrzej, Chmielarz, Mateusz, Uryga, Anna, Środa-Pomianek, Kamila, Palko-Łabuz, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9145895/
https://www.ncbi.nlm.nih.gov/pubmed/35630703
http://dx.doi.org/10.3390/molecules27103227
_version_ 1784716427554455552
author Teisseyre, Andrzej
Chmielarz, Mateusz
Uryga, Anna
Środa-Pomianek, Kamila
Palko-Łabuz, Anna
author_facet Teisseyre, Andrzej
Chmielarz, Mateusz
Uryga, Anna
Środa-Pomianek, Kamila
Palko-Łabuz, Anna
author_sort Teisseyre, Andrzej
collection PubMed
description Voltage-gated potassium channels of the Kv1.3 type are considered a potential new molecular target in several pathologies, including some cancer disorders and COVID-19. Lipophilic non-toxic organic inhibitors of Kv1.3 channels, such as statins and flavonoids, may have clinical applications in supporting the therapy of some cancer diseases, such as breast, pancreas, and lung cancer; melanoma; or chronic lymphocytic leukemia. This study focuses on the influence of the co-application of statins—simvastatin (SIM) or mevastatin (MEV)—with flavonoids 8-prenylnaringenin (8-PN), 6-prenylnarigenin (6-PN), xanthohumol (XANT), acacetin (ACAC), or chrysin on the activity of Kv1.3 channels, viability, and the apoptosis of cancer cells in the human T cell line Jurkat. We showed that the inhibitory effect of co-application of the statins with flavonoids was significantly more potent than the effects exerted by each compound applied alone. Combinations of simvastatin with chrysin, as well as mevastatin with 8-prenylnaringenin, seem to be the most promising. We also found that these results correlate with an increased ability of the statin–flavonoid combination to reduce viability and induce apoptosis in cancer cells compared to single compounds. Our findings suggest that the co-application of statins and flavonoids at low concentrations may increase the effectiveness and safety of cancer therapy. Thus, the simultaneous application of statins and flavonoids may be a new and promising anticancer strategy.
format Online
Article
Text
id pubmed-9145895
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-91458952022-05-29 Co-Application of Statin and Flavonoids as an Effective Strategy to Reduce the Activity of Voltage-Gated Potassium Channels Kv1.3 and Induce Apoptosis in Human Leukemic T Cell Line Jurkat Teisseyre, Andrzej Chmielarz, Mateusz Uryga, Anna Środa-Pomianek, Kamila Palko-Łabuz, Anna Molecules Article Voltage-gated potassium channels of the Kv1.3 type are considered a potential new molecular target in several pathologies, including some cancer disorders and COVID-19. Lipophilic non-toxic organic inhibitors of Kv1.3 channels, such as statins and flavonoids, may have clinical applications in supporting the therapy of some cancer diseases, such as breast, pancreas, and lung cancer; melanoma; or chronic lymphocytic leukemia. This study focuses on the influence of the co-application of statins—simvastatin (SIM) or mevastatin (MEV)—with flavonoids 8-prenylnaringenin (8-PN), 6-prenylnarigenin (6-PN), xanthohumol (XANT), acacetin (ACAC), or chrysin on the activity of Kv1.3 channels, viability, and the apoptosis of cancer cells in the human T cell line Jurkat. We showed that the inhibitory effect of co-application of the statins with flavonoids was significantly more potent than the effects exerted by each compound applied alone. Combinations of simvastatin with chrysin, as well as mevastatin with 8-prenylnaringenin, seem to be the most promising. We also found that these results correlate with an increased ability of the statin–flavonoid combination to reduce viability and induce apoptosis in cancer cells compared to single compounds. Our findings suggest that the co-application of statins and flavonoids at low concentrations may increase the effectiveness and safety of cancer therapy. Thus, the simultaneous application of statins and flavonoids may be a new and promising anticancer strategy. MDPI 2022-05-18 /pmc/articles/PMC9145895/ /pubmed/35630703 http://dx.doi.org/10.3390/molecules27103227 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Teisseyre, Andrzej
Chmielarz, Mateusz
Uryga, Anna
Środa-Pomianek, Kamila
Palko-Łabuz, Anna
Co-Application of Statin and Flavonoids as an Effective Strategy to Reduce the Activity of Voltage-Gated Potassium Channels Kv1.3 and Induce Apoptosis in Human Leukemic T Cell Line Jurkat
title Co-Application of Statin and Flavonoids as an Effective Strategy to Reduce the Activity of Voltage-Gated Potassium Channels Kv1.3 and Induce Apoptosis in Human Leukemic T Cell Line Jurkat
title_full Co-Application of Statin and Flavonoids as an Effective Strategy to Reduce the Activity of Voltage-Gated Potassium Channels Kv1.3 and Induce Apoptosis in Human Leukemic T Cell Line Jurkat
title_fullStr Co-Application of Statin and Flavonoids as an Effective Strategy to Reduce the Activity of Voltage-Gated Potassium Channels Kv1.3 and Induce Apoptosis in Human Leukemic T Cell Line Jurkat
title_full_unstemmed Co-Application of Statin and Flavonoids as an Effective Strategy to Reduce the Activity of Voltage-Gated Potassium Channels Kv1.3 and Induce Apoptosis in Human Leukemic T Cell Line Jurkat
title_short Co-Application of Statin and Flavonoids as an Effective Strategy to Reduce the Activity of Voltage-Gated Potassium Channels Kv1.3 and Induce Apoptosis in Human Leukemic T Cell Line Jurkat
title_sort co-application of statin and flavonoids as an effective strategy to reduce the activity of voltage-gated potassium channels kv1.3 and induce apoptosis in human leukemic t cell line jurkat
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9145895/
https://www.ncbi.nlm.nih.gov/pubmed/35630703
http://dx.doi.org/10.3390/molecules27103227
work_keys_str_mv AT teisseyreandrzej coapplicationofstatinandflavonoidsasaneffectivestrategytoreducetheactivityofvoltagegatedpotassiumchannelskv13andinduceapoptosisinhumanleukemictcelllinejurkat
AT chmielarzmateusz coapplicationofstatinandflavonoidsasaneffectivestrategytoreducetheactivityofvoltagegatedpotassiumchannelskv13andinduceapoptosisinhumanleukemictcelllinejurkat
AT urygaanna coapplicationofstatinandflavonoidsasaneffectivestrategytoreducetheactivityofvoltagegatedpotassiumchannelskv13andinduceapoptosisinhumanleukemictcelllinejurkat
AT srodapomianekkamila coapplicationofstatinandflavonoidsasaneffectivestrategytoreducetheactivityofvoltagegatedpotassiumchannelskv13andinduceapoptosisinhumanleukemictcelllinejurkat
AT palkołabuzanna coapplicationofstatinandflavonoidsasaneffectivestrategytoreducetheactivityofvoltagegatedpotassiumchannelskv13andinduceapoptosisinhumanleukemictcelllinejurkat